Thioredoxin as a putative biomarker and candidate target in age-related immune decline

Biochemical Society Transactions

Volumn 42, Issue 4, 2014, Pages 922-927

  Griffiths, Helen R ^a   Bennett, Stuart J ^a   Olofsson, Peter ^b   Dunston, Christopher R ^a  

^a ASTON UNIVERSITY   (United Kingdom)

^b Redoxis AB Sahlgrenska Science Park ^*  (Sweden)

Author keywords

Ageing; Oxidation; Reactive oxygen species (ROS); Rheumatoid arthritis; Thiol; Thioredoxin

Indexed keywords

THIOREDOXIN 1; THIOREDOXIN INTERACTING PROTEIN; BIOLOGICAL MARKER; THIOREDOXIN;

AGING; CARDIOVASCULAR DISEASE; CELL SURFACE; CONFERENCE PAPER; ENZYME METABOLISM; GERIATRIC DISORDER; HUMAN; IMMUNE SYSTEM; IMMUNOPATHOLOGY; MALIGNANT NEOPLASTIC DISEASE; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; RHEUMATOID ARTHRITIS; RISK FACTOR; T LYMPHOCYTE; ANIMAL; BIOLOGICAL MODEL; METABOLISM; PHYSIOLOGY;

AGING; ANIMALS; BIOLOGICAL MARKERS; HUMANS; MODELS, BIOLOGICAL; T-LYMPHOCYTES; THIOREDOXINS;

EID: 84905866456     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20140162     Document Type: Conference Paper

References (51)

1. Laurent, T.C., Moore, E.C. and Reichard, P. (1964) Enzymatic synthesis of deoxyribonucleotides. IV. Isolation and characterization of thioredoxin, the hydrogen donor from Escherichia coli B. J. Biol. Chem. 239, 3436-3444
2. Nakamura, H., Nakamura, K. and Yodoi, J. (1997) Redox regulation of cellular activation. Annu. Rev. Immunol. 15, 351-369
3. Metcalfe, C., Cresswell, P. and Barclay, A.N. (2012) Interleukin-2 signalling is modulated by a labile disulfide bond in the CD132 chain of its receptor. Open Biol. 2, 110036
4. Metcalfe, C., Cresswell, P., Ciaccia, L., Thomas, B. and Barclay, A.N. (2011) Labile disulfide bonds are common at the leucocyte cell surface. Open Biol. 1, 110010
5. Lillig, C.H. and Holmgren, A. (2007) Thioredoxin and related molecules: from biology to health and disease. Antioxid. Redox Signal. 9, 25-47
6. Holmgren, A. (1985) Thioredoxin. Annu. Rev. Biochem. 54, 237-271
7. Benhar, M., Thompson, J.W., Moseley, M.A. and Stamler, J.S. (2010) Identification of S-nitrosylated targets of thioredoxin using a quantitative proteomic approach. Biochemistry 49, 6963-6969
8. Hashemy, S.I. and Holmgren, A. (2008) Regulation of the catalytic activity and structure of human thioredoxin 1 via oxidation and S-nitrosylation of cysteine residues. J. Biol. Chem. 283, 21890-21898
9. Winterbourn, C.C. and Hampton, M.B. (2008) Thiol chemistry and specificity in redox signaling. Free Radic. Biol. Med. 45, 549-561
10. King, B.C., Nowakowska, J., Karsten, C.M., Kohl, J., Renstrom, E. and Blom, A.M. (2012) Truncated and full-length thioredoxin-1 have opposing activating and inhibitory properties for human complement with relevance to endothelial surfaces. J. Immunol. 188, 4103-4112
11. Makhadiyeva, D., Lam, L., Moatari, M., Vallance, J., Zheng, Y., Campbell, E.C. and Powis, S.J. (2012) MHC class I dimer formation by alteration of the cellular redox environment and induction of apoptosis. Immunology 135, 133-139
12. Gallegos, A., Gasdaska, J.R., Taylor, C.W., Paine-Murrieta, G.D., Goodman, D., Gasdaska, P.Y., Berggren, M., Briehl, M.M. and Powis, G. (1996) Transfection with human thioredoxin increases cell proliferation and a dominant-negative mutant thioredoxin reverses the transformed phenotype of human breast cancer cells. Cancer Res. 56, 5765-5770
13. Hirota, K., Murata, M., Sachi, Y., Nakamura, H., Takeuchi, J., Mori, K. and Yodoi, J. (1999) Distinct roles of thioredoxin in the cytoplasm and in the nucleus: a two-step mechanism of redox regulation of transcription factor NF-κB. J. Biol. Chem. 274, 27891-27897
14. Ueno, M., Masutani, H., Arai, R.J., Yamauchi, A., Hirota, K., Sakai, T., Inamoto, T., Yamaoka, Y., Yodoi, J. and Nikaido, T. (1999) Thioredoxin-dependent redox regulation of p53-mediated p21 activation. J. Biol. Chem. 274, 35809-35815
15. Mahmood, D.F., Abderrazak, A., El Hadri, K., Simmet, T. and Rouis, M. (2013) The thioredoxin system as a therapeutic target in human health and disease. Antioxid. Redox Signal. 19, 1266-1303
16. Mahmood, D.F., Abderrazak, A., Couchie, D., Lunov, O., Diderot, V., Syrovets, T., Slimane, M.N., Gosselet, F., Simmet, T., Rouis, M. and El Hadri, K. (2013) Truncated thioredoxin (Trx-80) promotes pro-inflammatory macrophages of the M1 phenotype and enhances atherosclerosis. J. Cell. Physiol. 228, 1577-1583
17. Holmgren, A. and Lu, J. (2010) Thioredoxin and thioredoxin reductase: current research with special reference to human disease. Biochem. Biophys. Res. Commun. 396, 120-124
18. Meng, L., Wong, J.H., Feldman, L.J., Lemaux, P.G. and Buchanan, B.B. (2010) A membrane-associated thioredoxin required for plant growth moves from cell to cell, suggestive of a role in intercellular communication. Proc. Natl. Acad. Sci. U.S.A. 107, 3900-3905
19. West, L.C. and Cresswell, P. (2013) Expanding roles for GILT in immunity. Curr. Opin. Immunol. 25, 103-108
20. Maekawa, A., Schmidt, B., Fazekas de St Groth, B., Sanejouand, Y.H. and Hogg, P.J. (2006) Evidence for a domain-swapped CD4 dimer as the coreceptor for binding to class II MHC. J. Immunol. 176, 6873-6878
21. Castellani, P., Angelini, G., Delfino, L., Matucci, A. and Rubartelli, A. (2008) The thiol redox state of lymphoid organs is modified by immunization: role of different immune cell populations. Eur. J. Immunol. 38, 2419-2425
22. Angelini, G., Gardella, S., Ardy, M., Ciriolo, M.R., Filomeni, G., Di Trapani, G., Clarke, F., Sitia, R. and Rubartelli, A. (2002) Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation. Proc. Natl. Acad. Sci. U.S.A. 99, 1491-1496
23. Curbo, S., Gaudin, R., Carlsten, M., Malmberg, K.J., Troye-Blomberg, M., Ahlborg, N., Karlsson, A., Johansson, M. and Lundberg, M. (2009) Regulation of interleukin-4 signaling by extracellular reduction of intramolecular disulfides. Biochem. Biophys. Res. Commun. 390, 1272-1277
24. Kondo, N., Ishii, Y., Kwon, Y.W., Tanito, M., Sakakura-Nishiyama, J., Mochizuki, M., Maeda, M., Suzuki, S., Kojima, M., Kim, Y.C. et al. (2007) Lipid raft-mediated uptake of cysteine-modified thioredoxin-1: apoptosis enhancement by inhibiting the endogenous thioredoxin-1. Antioxid. Redox Signal. 9, 1439-1448
25. Phillips, D.C., Dias, H.K., Kitas, G.D. and Griffiths, H.R. (2010) Aberrant reactive oxygen and nitrogen species generation in rheumatoid arthritis (RA): causes and consequences for immune function, cell survival, and therapeutic intervention. Antioxid. Redox Signal. 12, 743-785
26. Carilho Torrao, R.B., Dias, I.H., Bennett, S.J., Dunston, C.R. and Griffiths, H.R. (2013) Healthy ageing and depletion of intracellular glutathione influences T cell membrane thioredoxin-1 levels and cytokine secretion. Chem. Cent. J. 7, 150
27. Szabo-Taylor, K.E., Eggleton, P., Turner, C.A., Faro, M.L., Tarr, J.M., Toth, S., Whiteman, M., Haigh, R.C., Littlechild, J.A. and Winyard, P.G. (2012) Lymphocytes from rheumatoid arthritis patients have elevated levels of intracellular peroxiredoxin 2, and a greater frequency of cells with exofacial peroxiredoxin 2, compared with healthy human lymphocytes. Int. J. Biochem. Cell Biol. 44, 1223-1231
28. Turner, J.E., Bennett, S.J., Campbell, J.P., Bosch, J.A., Aldred, S. and Griffiths, H.R. (2013) The antioxidant enzyme peroxiredoxin-2 is depleted in lymphocytes seven days after ultra-endurance exercise. Free Radic. Res. 47, 821-828
29. Griffiths, H.R., Dunston, C.R., Bennett, S.J., Grant, M.M., Phillips, D.C. and Kitas, G.D. (2011) Free radicals and redox signalling in T-cells during chronic inflammation and ageing. Biochem. Soc. Trans. 39, 1273-1278
30. Torrao, R.C., Bennett, S.J., Brown, J.E. and Griffiths, H.R. (2014) Does metabolic reprogramming underpin age-associated changes in T cell phenotype and function? Free Radic. Biol. Med. 71C, 26-35
31. Mougiakakos, D., Johansson, C.C., Jitschin, R., Bottcher, M. and Kiessling, R. (2011) Increased thioredoxin-1 production in human naturally occurring regulatory T cells confers enhanced tolerance to oxidative stress. Blood 117, 857-861
32. Pekkari, K. and Holmgren, A. (2004) Truncated thioredoxin: physiological functions and mechanism. Antioxid. Redox Signal. 6, 53-61
33. Lemarechal, H., Anract, P., Beaudeux, J.L., Bonnefont-Rousselot, D., Ekindjian, O.G. and Borderie, D. (2007) Expression and extracellular release of Trx80, the truncated form of thioredoxin, by TNF-κ- and IL-1β-stimulated human synoviocytes from patients with rheumatoid arthritis. Clin. Sci. 113, 149-155
34. Jung, H. and Choi, I. (2014) Thioredoxin-interacting protein, hematopoietic stem cells, and hematopoiesis. Curr. Opin. Hematol. 21, 265-270
35. Okuyama, H., Yoshida, T., Son, A., Oka, S., Wang, D., Nakayama, R., Masutani, H., Nakamura, H., Nabeshima, Y. and Yodoi, J. (2009) Thioredoxin binding protein 2 modulates natural killer T cell-dependent innate immunity in the liver: possible link to lipid metabolism. Antioxid. Redox Signal. 11, 2585-2593
36. Okuyama, H., Son, A., Ahsan, M.K., Masutani, H., Nakamura, H. and Yodoi, J. (2008) Thioredoxin and thioredoxin binding protein 2 in the liver. IUBMB Life 60, 656-660
37. Yoshida, T., Kondo, N., Oka, S., Ahsan, M.K., Hara, T., Masutani, H., Nakamura, H. and Yodoi, J. (2006) Thioredoxin-binding protein-2 (TBP-2): its potential roles in the aging process. BioFactors 27, 47-51
38. Zhuo de, X., Niu, X.H., Chen, Y.C., Xin, D.Q., Guo, Y.L. and Mao, Z.B. (2010) Vitamin D3 up-regulated protein 1 (VDUP1) is regulated by FOXO3A and miR-17-5p at the transcriptional and post-transcriptional levels, respectively, in senescent fibroblasts. J. Biol. Chem. 285, 31491-31501
39. Yoshida, T., Nakamura, H., Masutani, H. and Yodoi, J. (2005) The involvement of thioredoxin and thioredoxin binding protein-2 on cellular proliferation and aging process. Ann. N.Y. Acad. Sci. 1055, 1-12
40. Sverdlov, A.L., Chan, W.P., Procter, N.E., Chirkov, Y.Y., Ngo, D.T. and Horowitz, J.D. (2013) Reciprocal regulation of NO signaling and TXNIP expression in humans: impact of aging and ramipril therapy. Int. J. Cardiol. 168, 4624-4630
41. Perez, V.I., Cortez, L.A., Lew, C.M., Rodriguez, M., Webb, C.R., Van Remmen, H., Chaudhuri, A., Qi, W., Lee, S., Bokov, A. et al. (2011) Thioredoxin 1 overexpression extends mainly the earlier part of life span in mice. J. Gerontol. A Biol. Sci. Med. Sci. 66, 1286-1299
42. Salmon, A.B., Flores, L.C., Li, Y., Van Remmen, H., Richardson, A. and Ikeno, Y. (2012) Reduction of glucose intolerance with high fat feeding is associated with anti-inflammatory effects of thioredoxin 1 overexpression in mice. Pathobiol. Aging Age Relat. Dis. 2, 17101
43. Arranz, L., Caamano, J.H., Lord, J.M. and de la Fuente, M. (2010) Preserved immune functions and controlled leukocyte oxidative stress in naturally long-lived mice: possible role of nuclear factor B. J. Gerontol. A Biol. Sci. Med. Sci. 65, 941-950
44. Butcher, S.K., Chahal, H., Nayak, L., Sinclair, A., Henriquez, N.V., Sapey, E., O'Mahony, D. and Lord, J.M. (2001) Senescence in innate immune responses: reduced neutrophil phagocytic capacity and CD16 expression in elderly humans. J. Leukoc. Biol. 70, 881-886
45. Vallejo, A.N. (2006) Age-dependent alterations of the T cell repertoire and functional diversity of T cells of the aged. Immunol. Res. 36, 221-228
46. Wang, P., Wu, Y., Li, X., Ma, X. and Zhong, L. (2013) Thioredoxin and thioredoxin reductase control tissue factor activity by thiol redox-dependent mechanism. J. Biol. Chem. 288, 3346-3358
47. Inomata, Y., Tanihara, H., Tanito, M., Okuyama, H., Hoshino, Y., Kinumi, T., Kawaji, T., Kondo, N., Yodoi, J. and Nakamura, H. (2008) Suppression of choroidal neovascularization by thioredoxin-1 via interaction with complement factor H. Invest. Ophthalmol. Vis. Sci. 49, 5118-5125
48. Kabuyama, Y., Kitamura, T., Yamaki, J., Homma, M.K., Kikuchi, S. and Homma, Y. (2008) Involvement of thioredoxin reductase 1 in the regulation of redox balance and viability of rheumatoid synovial cells. Biochem. Biophys. Res. Commun. 367, 491-496
49. Hultqvist, M., Olofsson, P., Wallner, F.K. and Holmdahl, R. (2014) Pharmacological potential of NOX2 agonists in inflammatory conditions. Antioxid. Redox Signal., doi:10.1089/ars.2013.5788
50. Griffiths, H.R., Dias, I.H., Willetts, R.S. and Devitt, A. (2014) Redox regulation of protein damage in plasma. Redox Biol. 2, 430-435
51. Omata, Y., Folan, M., Shaw, M., Messer, R.L., Lockwood, P.E., Hobbs, D., Bouillaguet, S., Sano, H., Lewis, J.B. and Wataha, J.C. (2006) Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1). Toxicol. In Vitro 20, 882-890